Molecular epidemiology and characterization of genotypes of Acinetobacter baumannii isolates from regions of south China

Japanese Journal of Infectious Diseases

Volumn 69, Issue 3, 2016, Pages 180-185

  Ying, Jun ^a   Lu, Junwan ^b   Zong, Li ^a   Li, Ailing ^a   Pan, Ruowang ^c   Cheng, Cong ^b   Li, Kunpeng ^a,d   Chen, Liqiang ^a,e   Ying, Jianchao ^a   Tou, Huifen ^a,f   Zhu, Chuanxin ^f   Xu, Teng ^a   Yi, Huiguang ^a   Li, Jinsong ^a   Ni, Liyan ^a   Xu, Zuyuan ^a   Bao, Qiyu ^a   Li, Peizhen ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b LISHUI UNIVERSITY   (China)

^c The 118th PLA Hospital   (China)

^d JIANGNAN UNIVERSITY   (China)

^e FUDAN UNIVERSITY   (China)

^f Wenzhou Municipal Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; ACINETOBACTER INFECTIONS; ALLELE; BACTERIUM IDENTIFICATION; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MULTIGENE FAMILY; PHYLOGENY;

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ALLELES; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHINA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; MULTIGENE FAMILY; MULTILOCUS SEQUENCE TYPING; PHYLOGENY;

EID: 84969219423     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.JJID.2014.544     Document Type: Article

References (20)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538-82.
2. Higgins PG, Dammhayn C, Hackel M, et al. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010;65:233-8.
3. Markogiannakis H, Pachylaki N, Samara E, et al. Infections in a surgical intensive care unit of a university hospital in Greece. Int J Infect Dis. 2009;13:145-53.
4. Yu YS. Multi-drug resistant Acinetobacter baumannii-gram negative “MRSA” in 21st century. Chin J Clin Infect Dis. 2009;2: 65-8.
5. Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing: 22th informational supplement. Document M100-S22. Wayne, PA: CLSI; 2012.
6. Ribot EM, Fair MA, Gautom R, et al. Standardization of pulsedfield gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis. 2006;3:59-67.
7. Le Hello S, Falcot V, Lacassin F, et al. Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific. Scand J Infect Dis. 2010;42:821-6.
8. Kitchel B, Rasheed JK, Patel JB, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009;53:3365-70.
9. Hamouda A, Evans BA, Towner KJ, et al. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla (OXA-51-like) genes. J Clin Microbiol. 2010;48:2476-83.
10. Park YK, Peck KR, Cheong HS, et al. Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea. Emerg Infect Dis. 2009;15:1325-7.
11. Alvargonzalez JJ, Vindel Hernando A, Martin MD, et al. Sequential outbreaks in a Spanish hospital caused by multiresistant OXA-58-producing Acinetobacter baumannii ST92. J Med Microbiol. 2014;63(Pt 8):1093-8.
12. Runnegar N, Sidjabat H, Goh HM, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J Clin Microbiol. 2010;48:4051-6.
13. Adams-Haduch JM, Onuoha EO, Bogdanovich T, et al. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol. 2011;49: 3849-54.
14. He C, Xie Y, Fan H, et al. Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China. Int J Antimicrob Agents. 2011;38:257-60.
15. Zhong Q, Xu W, Wu Y, et al. Clonal spread of carbapenem nonsusceptible Acinetobacter baumannii in an intensive care unit in a teaching hospital in China. Ann Lab Med. 2012;32:413-9.
16. Li Yj, Pan Cz, Zhao Zw, et al. Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China. BMC Infect Dis. 2013;13:548.
17. Wang X, Qiao F, Yu R, et al. Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study. BMC Microbiol. 2013;13:234.
18. Fu Y, Zhou J, Zhou H, et al. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J Antimicrob Chemother. 2010;65:644-50.
19. Deng M, Zhu MH, Li JJ, et al. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital. Antimicrob Agents Chemother. 2014;58:297-303.
20. Zhang L, Yang WH, Xiao M, et al. Mohnarin annual report 2010: surveillance of antimicrobial resistance in bacteria isolated from intensive care units. Chin J Nosocomiol. 2012;22:34-8.